Nature of the Collaboration Sample Clauses

Nature of the Collaboration. Company and Partner agree to use their good faith, reasonable efforts to engage in mutually beneficial collaboration in support of the Project as set out in Exhibit A (Description of technical partnership and responsibilities) and Exhibit B (Description of initiatives around PR and co-marketing).
AutoNDA by SimpleDocs
Nature of the Collaboration. 3.1. DAISI will provide: 3.1.1. Visiting specialist doctors free of charge for one to two week visits to Alotau Provincial Hospital, Milne Bay, Papua New Guinea when requested and adequately prepared for by Alotau Provincial Hospital, and Milne Bay Health Authority. 3.2. Alotau Provincial Hospital and Milne Bay Health Authority will provide: 3.2.1. Provision of administrative support for projects, including but not limited to any exemption request towards DAISI specialist training missions project supplies or DAISI project personnel; and 3.2.2. In country administrative support for organisation of support to activities in liaison with DAISI personnel. 3.2.3. Free registration to DAISI members who meet criteria for temporary medical and nursing registration to practice in PNG. 3.2.4. Necessary screening and recruitment of patients for specialist visits. 3.2.5. Necessary medical and nursing staff to ensure the safe delivery of specialist services and teaching. 3.2.6. Doctors from Alotau Provincial Hospital, Milne Bay to attend DAISI specialists training missions who specifically require training in specialty areas of medicine and surgery in order for DAISI to meet its key objective of training local doctors.
Nature of the Collaboration. The parties are entering into this MOU on the basis that they are equal partners who bring different and yet complementary strengths to the tasks of: • creating “pro-poor” cities that integrate rather than marginalize the interests of slum dwellers and countering the dominant urban development approaches which so often exclude them; • collaborating (in the cities and towns of Africa where AAPS member schools have a presence) to expose students of city/town/regional planning to the issues and needs of those living and working in informal settlements, so that as professionals they will work directly or indirectly to promote inclusive and pro-poor urban settlements; • Exchanging ideas on the development of curricula in planning and the built environment. • Joint research and collaboration on the documentation and dissemination of successful cases of pro-poor intervention, both for use in teaching and to influence policy-makers. The two organisations commit themselves to the common goal of jointly delivering to the highest level of quality. Their relationship in taking forward this goal will be underpinned by principles of transparency and trust. All research and publication collaborations will adhere to the principles of ethical research, the right to privacy and informed consent. This includes sensitivity to cultural diversity, confidentiality and anonymity. It is acknowledged that both institutions have different agendas and processes, but are partnering towards a common goal. In the spirit of the collaboration, each entity will respect the autonomy, experience and timelines of the other. It is intended that the collaboration is undertaken with the Partners equally sharing risks and benefits associated with the objectives of the collaboration. The use of the term “Partner” in this agreement is not intended in a way that implies the creation of a legal partnership, joint venture or any other kind of legal entity between (AAPS) and (SDI) in order to implement the collaboration. It is rather used to express a collaboration in which both members have equal status.
Nature of the Collaboration. 3.1. DAISI will provide: 3.1.1. Visiting specialist doctors free of charge for one to two week visits to public hospitals (VCH & NPH) when requested and adequately prepared for by Vanuatu Ministry for Health. 3.2. The GoV will provide: 3.2.1. Provision of administrative support for the project, including but not limited to any exemption request towards DAISI specialist training missions project supplies or DAISI project personnel; and 3.2.2. In country administrative support for organisation of support to activities in liaison with DAISI personnel. 3.2.3. Free registration to DAISI members who meet criteria for temporary medical and nursing registration to practice in Vanuatu. 3.2.4. Necessary screening and recruitment of patients for specialist visits. 3.2.5. Necessary medical and nursing staff to ensure the safe delivery of specialist services and teaching. 3.2.6. Doctors from Vanuatu to attend DAISI specialists training missions who specifically require training in specialty areas of medicine and surgery in order for DAISI to meet its key objective of training local doctors.
Nature of the Collaboration. 3.1. DAISI will provide: 3.1.1. Visiting specialist doctors free of charge for one to two week visits to Sopas District and Enga Provincial hospitals when requested and adequately prepared for by Sopas District and Enga Provincial Hospitals(PNG) and the Enga Province Health Authority (EPHA) 3.2. The Sopas District and Enga Provincial Hospital will provide: 3.2.1. Provision of administrative support for the project, including but not limited to any exemption request towards DAISI specialist training missions project supplies or DAISI project personnel; and 3.2.2. In country administrative support for organisation of support to activities in liaison with DAISI personnel. 3.2.3. Free registration to DAISI members who meet criteria for temporary medical and nursing registration to practice in PNG. 3.2.4. Necessary screening and recruitment of patients for specialist visits. 3.2.5. Necessary medical and nursing staff to ensure the safe delivery of specialist services and teaching. 3.2.6. Doctors from Sopas District and Enga Provincial Hospitals (PNG) to attend DAISI specialists training missions who specifically require training in specialty areas of medicine and surgery in order for DAISI to meet its key objective of training local doctors.
Nature of the Collaboration. This MoU describes the framework for the future management of works within Reserves by DWAG, dependant on contract renewal.  DWAG is required to maintain its legal identity, public liability and workers compensation insurance policies.  DWAG are encouraged to seek grant funding on behalf of the Shire from Federal, State and/or other agencies to work in Denmark’s Reserves to help maintain biodiversity.  To facilitate communication between DWAG, contractors and Shire employees working in Reserves to ensure that all works are conducted in a manner that maximises the resources used to fund and conduct works within Reserves on a priority basis.  To ensure that contractors and Shire employees are aware of the location and extent of works conducted by DWAG and funded by Federal, State and Local Government bodies.  To ensure that integrated weed management is effective.
Nature of the Collaboration. Subject to the terms and conditions of this Agreement, Introgen shall conduct research and development activities directed to the Field as part of a collaborative Program as set forth herein. As between the Parties, Introgen shall be responsible for conducting the research and development activities of the Program and shall keep Colgate informed, through the Steering Committee described below, as to the progress thereof, and will consult with the Steering Committee regarding the direction and goals of the Program, all as described in this Article 2. In addition, Colgate may from time to time undertake additional activities relating to the Program, as Colgate may determine or the Parties agree, and will keep the Steering Committee informed of those activities.
AutoNDA by SimpleDocs

Related to Nature of the Collaboration

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Scope of Collaboration As part of the collaboration, the Controllers will act as Joint Controller. The roles of the Controller and the associated tasks are specified in more detail in Appendix 1. If one party is solely responsible for a data processing operation, this party will implement all relevant data protection provisions on its own responsibility. However, such data processing procedures are not subject to this Agreement. Joint data processing and the type of Personal Data collected and processed within the framework of collaboration are specified in Appendix 1.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Development of the Property Except as modified by this Agreement, the Development and the Property will be developed in accordance with all applicable local, state, and federal regulations, including but not limited to the City’s ordinances and the zoning regulations applicable to the Property, and such amendments to City ordinances and regulations that that may be applied to the Development and the Property under Chapter 245, Texas Local Government Code, and good engineering practices (the “Applicable Regulations”). If there is a conflict between the Applicable Regulations and the Development Standards, the Development Standards shall control.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Research Matters By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent’s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Project The findings of any research project, which would change the provisions of this Agreement will not be implemented until such changes are negotiated and agreed to by the parties.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!